Percheron Therapeutics Limited (ASX:PER)
About Percheron Therapeutics Limited
Key Information
PER In the News
No news found.
ASX Announcements
Date | Announcement | File | Views |
---|---|---|---|
26/04/2024 | Change in substantial holding | 224.86KB | 696 |
02/04/2024 | ATL1102 Clinical Trial Update | 254.91KB | 5.3K |
04/03/2024 | ATL1102 Data presented at MDA Annual Conference | 2.1MB | 3.8K |
28/02/2024 | Price Sensitive PS Half Yearly Report and Accounts | 9.38MB | 1.1K |
26/02/2024 | Percheron Therapeutics Limited Corporate Presentation | 1.7MB | 7.3K |
21/02/2024 | Change of Registered Office and Principal Place of Business | 176.34KB | 1.5K |
12/02/2024 | Price Sensitive PS Receipt of R&D Tax incentive payment | 174.65KB | 9.2K |
31/01/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 325.23KB | 30K |